6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Illegal Drugs and Heart Diseases
A medication is a substance that influences the manner in which the body capacities. On the off chance that a medication is delegated 'unlawful', this implies that it is prohibited by law. Distinctive illicit medications effectively affect individuals and these impacts are impacted by numerous variables. This makes them eccentric and hazardous, particularly for youngsters.
In contrast to cardiovascular illness, which incorporates issues with the whole circulatory framework, coronary illness influences just the heart. As indicated by the Centers for Disease Control and Prevention (CDC), coronary illness is the main source of death in the United States. Around 1 out of 4 passing's in the U.S. happen because of coronary illness, and it influences all genders just as all racial and ethnic gatherings.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States